Evidence map›Paper›PMID 33512764›Full record

ArticleEMBO reports2021

EVL regulates VEGF receptor-2 internalization and signaling in developmental angiogenesis.

Joana Zink, Maike Frye, Timo Frömel, Claudia Carlantoni, David John, Danny Schreier, Andreas Weigert, Hebatullah Laban, Gabriela Salinas, Heike Stingl and 9 more

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. PI(4,5)PScience advances · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Gatekeeping role ofScience advances · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Joana ZinkCentre for Molecular Medicine, Institute for Vascular Signalling, Goethe University, Frankfurt am Main, Germany.
Maike FryeInstitute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-6257-7636
Timo FrömelCentre for Molecular Medicine, Institute for Vascular Signalling, Goethe University, Frankfurt am Main, Germany.
Claudia CarlantoniInstitute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
David JohnGerman Centre of Cardiovascular Research (DZHK), Partner site Rhein-Main, Frankfurt am Main, Germany.
Danny SchreierInstitute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Andreas WeigertInstitute of Biochemistry I-Pathobiochemistry, Faculty of Medicine, Goethe-University, Frankfurt am Main, Germany.
Hebatullah LabanDepartment of Cardiovascular Physiology, Institute of Physiology and Pathophysiology, Heidelberg University, Heidelberg, Germany.
Gabriela SalinasNGS-Integrative Genomics Core Unit (NIG), Institute of Human Genetics, University Medical Center Göttingen (UMG), Göttingen, Germany.
Heike StinglCentre for Molecular Medicine, Institute for Vascular Signalling, Goethe University, Frankfurt am Main, Germany.
Lea GüntherCentre for Molecular Medicine, Institute for Vascular Signalling, Goethe University, Frankfurt am Main, Germany.
Rüdiger PoppCentre for Molecular Medicine, Institute for Vascular Signalling, Goethe University, Frankfurt am Main, Germany.
Jiong HuCentre for Molecular Medicine, Institute for Vascular Signalling, Goethe University, Frankfurt am Main, Germany.
Benoit VanhollebekeLaboratory of Neurovascular Signaling, ULB Neuroscience Institute Department of Molecular Biology, University of Brussels, Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Brussels, Belgium.ORCID 0000-0002-0353-365X
Hannes SchmidtInterfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.
Amparo Acker-PalmerInstitute of Cell Biology and Neuroscience and Buchmann Institute for Molecular Life Sciences, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0002-8107-927X
Thomas RennéInstitute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ingrid FlemingCentre for Molecular Medicine, Institute for Vascular Signalling, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0003-1881-3635
Peter M BenzCentre for Molecular Medicine, Institute for Vascular Signalling, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0002-3994-8937
Goethe University Frankfurt · DEUniversität Hamburg · DEHeidelberg University · DEUniversitätsmedizin Göttingen · DEUniversity of Tübingen · DEWalloon Excellence in Lifesciences and Biotechnology · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelial tip cells are essential for VEGF-induced angiogenesis, but underlying mechanisms are elusive. The Ena/VASP protein family, consisting of EVL, VASP, and Mena, plays a pivotal role in axon guidance. Given that axonal growth cones and endothelial tip cells share many common features, from the morphological to the molecular level, we investigated the role of Ena/VASP proteins in angiogenesis. EVL and VASP, but not Mena, are expressed in endothelial cells of the postnatal mouse retina. Global deletion of EVL (but not VASP) compromises the radial sprouting of the vascular plexus in mice. Similarly, endothelial-specific EVL deletion compromises the radial sprouting of the vascular plexus and reduces the endothelial tip cell density and filopodia formation. Gene sets involved in blood vessel development and angiogenesis are down-regulated in EVL-deficient P5-retinal endothelial cells. Consistently, EVL deletion impairs VEGF-induced endothelial cell proliferation and sprouting, and reduces the internalization and phosphorylation of VEGF receptor 2 and its downstream signaling via the MAPK/ERK pathway. Together, we show that endothelial EVL regulates sprouting angiogenesis via VEGF receptor-2 internalization and signaling.

Indexed as

Endothelial CellsNeovascularization, PhysiologicVascular Endothelial Growth Factor Receptor-2AnimalsCell Adhesion MoleculesMiceMorphogenesisSignal TransductionCell Adhesion MoleculesEvl protein, mouseKdr protein, mouseVascular Endothelial Growth Factor Receptor-2Ena/VASP proteinsendothelial cellssprouting angiogenesistip cell filopodia formationVEGF receptor 2 internalization and signaling

Identifiers

PMID33512764
PMCPMC7857432
OpenAlexW3124963501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.